DT Investment Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

DT Investment Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-32	Closed	-$2.97K	–	665
2024 Q2	$2.97K	Buy	+32	New	+$2.87K	﹤0.01%	465
2023 Q2	–	Sell	-275	Closed	-$22.6K	–	477
2023 Q1	$22.6K	Buy	+275	New	+$22.8K	﹤0.01%	257
2020 Q2	–	Sell	-13,411	Closed	-$1.04M	–	129
2020 Q1	$1.04M	Hold	13,411	–	–	0.17%	53
2019 Q4	$1.28M	Buy	+13,411	New	+$1.16M	0.12%	83

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

DT Investment Partners's XBI Position: Q3 2024 in Review

DT Investment Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 32 shares — an estimated $2.97K sold.

DT Investment Partners first reported a position in XBI in Q4 2019 and held it in 4 quarters. The position peaked at $1.28M in Q4 2019. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

DT Investment Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
DT Investment Partners sold 32 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $2.97K.
DT Investment Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and held it in 4 quarters.
DT Investment Partners's State Street SPDR S&P Biotech ETF position peaked at $1.28M in Q4 2019.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on DT Investment Partners's 13F filing for Q3 2024, filed 23 Oct 2024.